Kenneth Macdonald asks whether pharmaceutical companies are pricing their drugs fairly and for how much longer the NHS can afford to pay exorbitant prices for medicines.
With the NHS facing deep cuts across the board, just how much should we be spending on medicines to treat a few rare diseases? Kenneth Macdonald investigates the drugs industry where lifesaving medicines can cost as much as a quarter-of-a-million pounds per patient, per year. Are the pharmaceutical companies pricing their drugs fairly? And how much longer can the NHS afford to pay these prices?